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Abstract  
In order to test therapeutics, functional assessments are required. In pre-clinical stroke 
research, there is little consensus regarding the most appropriate behavioural tasks to 
assess deficits; especially when testing over extended times in milder models with short 
occlusion times and small lesion volumes. In this study we comprehensively assessed 16 
different behavioural tests, with the aim of identifying those that show robust, reliable and 
stable deficits for up to 2 months. These tasks are regularly used in stroke research, as well 
as being useful for examining striatal dysfunction in models of Huntington’s and Parkinson’s 
disease. Two cohorts of male Wistar rats underwent the intraluminal filament model of 
MCAO (30min) and were imaged 24hrs later. This resulted in primarily subcortical infarcts, 
with a small amount of cortical damage. Animals were tested, along with sham and naïve 
groups at 24hrs, 7 days, and 1 and 2 months. Following behavioural testing, brains were 
processed and striatal neuronal counts were performed alongside measurements of total 
brain and white matter atrophy. The staircase, adjusting steps, rotarod and apomorphine 
induced rotations were the most reliable for assessing long-term deficits in the 30 min 
transient MCAO model of stroke.  
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Introduction 
Many rodent models of focal brain ischemia exist, but the most commonly employed is the 
intraluminal filament middle cerebral artery occlusion (MCAO) model of stroke 1. There is 
debate regarding the ability of different behavioural tasks to reveal reliable deficits in this 
model. Often rats recover sensori-motor function in the weeks following MCAO; many 
groups have shown that MCAO rats exhibit recovery or even compensation, particularly if 
tested for more than 7 days post-MCAO 2. Despite this, few studies assess behaviour for 
more than a few days post-ischemia. The Stroke Therapy Academic Industry Roundtable 
(STAIR) Preclinical Recommendations highlighted that measurement of behavioural 
outcomes for testing novel therapeutics should occur for at least 2 – 3 weeks post induction 
of focal ischemia 3. This is particularly important when considering the plethora of 
pathological changes that are occurring in the brain following the initial event. If chronic time 
points are not included, researchers cannot be certain that any potential intervention will 
have a long-term functional effect, which will be required for any novel therapy to progress 
to testing in patients. Functional outcomes are often not assessed until 3-6 months post-
stroke in clinical trials and, as in the rodent, patients often display a degree of recovery in 
the first few weeks following the stroke. Thus, to be able to develop therapeutics which will 
translate from bench to bedside, it is necessity to find stable long-term tests of neurological 
function in animal models. These tests need to be easy to administer, and preferably 
quantitative rather than qualitative in nature to reduce the risk of bias.  
In the current study, we comprehensively assessed the MCAO filament model of stroke in 
rats using 16 different behavioural tests. We evaluated tests that are commonly used in 
stroke models and introduce other tests that have proven extremely successful for detailed 
assessment of striatal dysfunction in models of Parkinson’s and Huntington’s disease. The 
aim was to identify tests that are sensitive to MCAO, and which show robust, reliable and 
stable deficits for up to 2 months. For this purpose, we chose a relatively specific lesion 
model with a small infarct volume, which would be more suitable for longer-term studies of 
neuroprotective and neurorepair strategies.  
 
Materials and methods 
A brief outline of the methods is below. Full details are provided in the supplemental 
methods. 
Animals 
Seventy-five male Wistar rats were divided into two cohorts (10-12 weeks old; Harlan, UK) 
and housed in groups of 3-4, in standard cages with wood shavings as bedding, nesting 
material, a tube, and aspen chew blocks. Prior to surgery, stratified randomisation was 
performed and animals were assigned to sham, naïve or MCAO groups based on baseline 
behaviour scores to negate any potential pre-existing differences in the groups. Following 
surgery animals were kept in the same cage groups where possible, meaning sham, naïve 
or MCAO animals were often housed together. The temperature (21±2°C), humidity 
(55±10%), and light cycle (14/10 hour light/dark cycle) of the environment was controlled. All 
experiments were performed within the same facility in accordance with the UK Animals 
(Scientific Procedures) Act 1986, under a project license approved and granted by the UK 
Home Office. Experiments are reported in accordance with the ARRIVE guidelines.  
Each experiment utilised a pre-defined exclusion criteria: (i) no restitution of cerebral blood 
flow (CBF) following removal of the filament (indicative of haemorrhage), n = 15 (all from the 
MCAO group);  (ii) incomplete MCAO, defined as absence of observable cortical or striatal 
changes during MRI at 24 h, n = 11 (all from the MCAO group); and (iii) post-operative 
weight loss of more than 20% of pre-surgical weight, n = 2 (all from the MCAO group). 
Additionally, 1 sham animal showed abnormalities at 24 h in the MRI and two other MCAO 
animals had complications during surgery. All of these animals were excluded prior to post-
surgical behavioural testing.  
The remaining 44 animals were allocated as follows: Cohort 1: 11 MCAO, 8 sham and 6 
naïve animals; Cohort 2: 9 MCAO, 5 sham and 5 naïve controls. The sham and naïve 
controls were subsequently combined to make one control group in each cohort following 
comparison to ascertain the absence of differences between them (supplemental methods 
A5). Sample sizes were selected based on previous work with other models of striatal injury 
on a selection of tasks, and with the rational that if deficits were not robust with these group 
sizes then studies for treatments, which would require significantly larger groups, would not 
be feasible. 
Middle cerebral artery occlusion 
Sham and 30 min MCAO procedures were carried out under isoflurane anaesthesia, using 
the method described in 4 to prevent damage to the facial musculature, as described fully in 
the supplemental methods (A1). During the procedure blood flow was monitored using a 
Laser Doppler Perfusion Monitor (Moor Instruments, Axminster, UK).  
MRI measurements and image analysis 
24 h following surgery, sham and MCAO animals underwent structural Multi-Slice Multi-Echo 
(MSME) T2 weighted MRI scans using a 9.4TBiospec with a rat head surface coil (Bruker 
BioSpin, Ettlingen, Germany). Analyze software (AnalyzeDirect, Overland Park, USA) was 
used to delineate manually the infarct and T2 values (ms) were recorded, as described fully 
in the supplemental methods (A2).  
Behavioural testing 
Methods and full protocols are provided for each behavioural test in the online supplemental 
data (Sections A and C), including practical advice and troubleshooting tips (C). All 
behavioural testing was performed by a blinded observer. Two cohorts of rats were used to 
reduce the number of tests each rat was exposed to.  
Food restriction 
Cohort 1 required food restriction to perform the food reward tasks. Their body weight was 
maintained at 85-90% of free feeding weight, by giving restricted amounts of food daily. This 
commenced 1 wk prior to baseline training and rats were returned to ad libitum feeding a 
week prior to surgery until 3 d prior to the commencement of testing at 4 wk post-MCAO.  
Experimental design 
All rats were trained on the behavioural tasks prior to surgery and were tested at 1 and 7 d, 
and 1 (4-5 wk) and 2 mo (8-9 wks) post-MCAO (Figure 1). Behavioural testing was carried 
out between the hours of 8 am and 7 pm and animals were tested in cage order.  
Following MCAO, both cohorts were tested for less than 12 min a day, with an extra 15 min 
a day for 25 days when Cohort 1 was tested on the staircase task, and an extra 150 min of 
drug-induced rotations (apomorphine & amphetamine) at the end of the study for Cohort 2.  
[Insert figure 1 here] 
 
Tissue processing and immunohistochemistry 
As described fully in the supplemental methods (A4), following perfusion fixation brains were 
sectioned and stained for NeuN  (1:4000, Chemicon, UK) and solochrome cyanine (Sigma 
Aldrich, UK 5) to allow visualization of neuronal nuclei and white matter tracts respectively. 
Sections were digitally photographed to determine final tissue and white matter loss using 
Image J (NIH, USA).  
Atrophy was calculated as  
  Whole brain atrophy = 100 * ((Hc–Vc) – (Hi–Vi)) / ((Hc–Vc) [3] 
  White matter atrophy = 100 *  (Wc-Wi) / Wc [4] 
where H, V, W, i, and c represent the volumes of the contralateral (c) and ipsilateral (i) 
hemisphere (H), ventricle (V), and white matter-stained (W) areas. 
Additionally, stereological neuronal counts of the entire right striatum of a 1 in 12 series 
using the Olympus C.A.S.T. grid system v1.6 were performed to estimate the total neuronal 
count for the striatum. One MCAO and one control animal from Cohort 1 and one control 
animal from Cohort 2 were excluded from the histological analysis due to tissue damage.  
 
Statistical analysis 
For full details of statistical analysis see the supplemental methods (A5). Briefly, behavioural 
data were tested for normality, and those measures which were normally distributed 
(rotarod, balance beam (latency to cross), corridor and gripstrength (force)) were analysed 
using a repeated measures ANCOVA, with baseline performance used as a co-variate. 
Those measures that were not normally distributed were analysed using the non-parametric 
Mann-Whitney test. Simple comparisons for normally distributed histological data were 
analysed using Student’s t-tests.  
Results 
Neuropathology  
The lesions induced cell loss in the lateral neocortex and striatum on the side of the 
infarction and atrophy of the hemisphere. The T2 maps indicated greater variability in the 
extent of the hyperintensity in Cohort 1 (Fig. 2F) than Cohort 2 (Fig. 2G), although this was 
not significant (Fig. 2A, U = 31, n.s.). Similarly, the MCAO lesioned animals in the two 
Cohorts did not exhibit significantly different infarct volumes (i.e. hemispheric atrophy), 
striatal or hemispheric white matter loss, or striatal neuronal loss (Figs 2B-E; t17 = 1.37, t17 = 
1.90, U = 25  and t17 = 0.05, respectively, all n.s.).    
[Insert figure 2 here] 
Behavioural measures 
 
For clarity of presentation, we have grouped the tests into 4 different broad categories: tests 
in which robust long-term deficits were observed in MCAO animals, tests in which the 
impairment was subtle and/or recovered spontaneously, tests in which the results were 
counter-intuitive, and tests in which no significant impairments in MCAO animals were 
observed. 
Tests that uncovered significant and stable deficits in the MCAO animals.   
 
Staircase task. MCAO rats collected fewer pellets with their contralateral paw than the 
corresponding paw in the Control group on the staircase test at 2 months post-surgery (Fig. 
3A: Block 2 - 4: U = 38 - 41, p < 0.05, Block 5: U = 45, p = 0.08), whereas they showed no 
deficits in the number of pellets retrieved on the ipsilateral side (U = 59 - 74, n.s.).  
 
Apomorphine-induced rotation. The MCAO animals exhibited a significant increase in the 
number of rotations to the ipsilateral side in response to apomorphine, this was in contrast to 
no net asymmetry in rotations in the Control animals (MCAO, 189.0 ± 169.3 vs. Controls, 3.4 
±  9.23 (Mean±SD);  U = 14, p < 0.01).  
[Insert figure 3 here] 
 
Tests in which the MCAO animals exhibited subtle deficits and/or recovery.  
 
Rotarod. Latency to fall off the Rotarod was significantly lower in the MCAO group when 
compared to the Control (Fig. 3B, F1,22 = 6.59, p<0.05). This deficit appeared to increase 
over time (MCAO x Time: F1,23 = 8.95, p < 0.01) such that the post hoc comparison between 
groups was only significant on the 2 mo time point (p<0.05). However, this effect was not 
due to a further decrease in performance in the MCAO group, but rather an improvement in 
the ability to remain on the Rotarod in the Control group.  
 
Lateralized stepping. The MCAO rats exhibited a paw bias, meaning they performed fewer 
steps with the contralateral paw than with the ipsilateral paw, although this deficit was not 
stable across all time points. They had a paw bias in the  forehand direction at 1 d and 2 mo 
(Fig. 3C, U = 72, p < 0.001, U = 100.5, p < 0.001) and in the backhand direction at 7 d and 1 
mo (Fig. 3C, U = 105, p < 0.05, U = 114, p < 0.01).  
 
Modified neuroscore. The score differed between MCAO and Control groups at 1 and 7 d 
post-MCAO (Fig. 3D; U = 104.0 and 123.5, respectively, both p<0.01); at both time points 
the MCAO animals scored higher (indicating reduced neurological function overall) but this 
was no longer the case at 1 and 2 mo (U = 212.5 and 162.0, respectively, both n.s.). 
 
Cage reaching task. MCAO rats took longer to achieve 20 successful reaches than Control 
animals at 1 mo (Fig. 3E, U = 28, p < 0.05). However, no other measures achieved 
significance.  
 
Corridor task. MCAO animals retrieved fewer pellets from the contralateral side in the 
corridor task at both 1 and 2 mo after surgery, in comparison to the absence of a side 
preference in the Control group. However, this difference did not achieve significance (Fig. 
3F, Groups, F1,22 = 4.14, p=0.054). 
 
Disengage task. Overall a larger response time to both contralateral and ipsilateral perioral 
stimulation without the chocolate distraction was evident in the MCAO group in comparison 
to the Control group at 1 mo (Figure 3G, Contra: U = 15.50, p < 0.05, Ipsi: U = 13, p < 0.01), 
but not at 2 mo (U = 43, 29, n.s.). When the chocolate distraction was introduced there was 
a significantly higher response time to perioral stimulation in the MCAO group on the 
ipsilateral side in comparison to the Control group at 1 mo (U = 11, p < 0.01) and 2 mo (U = 
10, p < 0.01). 
 
Ladder test. On the regular spaced rungs in the ladder task, there was a small but significant 
increase in the number of hindpaw slips exhibited by the MCAO group at 1 mo (Control 0.0 ± 
0.0, MCAO 0.08 ± 0.08 (Mean±SD); U = 20, p<0.05). However, there was also a reduction in 
forepaw slips in the MCAO group at 1 mo (Control 0.50 ± 0.40, MCAO 0.20 ± 0.36 
(Mean±SD); U = 20.5, p < 0.05). It should be noted that the number of overall foot slips 
made on the ladder with regular rungs was very low (means of 0.1 - 0.5 slips per traverse) 
and both groups crossed relatively quickly (10-12s; Fig 3H). In comparison, rats took almost 
twice as long to cross the ladder with irregularly spaced rungs (Fig. 3H, 18-25s). This 
slowing was most apparent in the MCAO group, but failed to achieve significance (U = 29 & 
24, n.s.). 
Tests in which the results were counterintuitive  
 
Swimming analysis. There were no significant differences in the number of fore or hindlimb 
strokes performed by the MCAO animals on either side when compared to the 
corresponding paws from the Control group (Fig. 4A, U = 24-44, n.s.). However, the MCAO 
animals were significantly faster at crossing the swim tank than the control animals (1 mo: 
2.26 ± 0.37 vs 2.82 ± 1.77 seconds, U = 10, p < 0.01. 2 mo: 2.41 ± 0.34 vs 3.03 ± 0.81 
seconds, U = 14, p < 0.01 (Mean ± SD)) 
 
Tapered balance beam. The MCAO group made significantly fewer contralateral forelimb 
slips on the beam in comparison with the control group at 2 mo (Fig 4C; U = 20.5, p < 0.05). 
However, MCAO animals were no faster in their latencies to cross the beam (F1,15 = 3.57, 
n.s).  
 
Gait analysis. A number of measures of gait were assessed. Distance between forepaws 
(base width) was unaltered in the MCAO group compared to the Control group (Fig. 4D; 
n.s.). Hindlimb base width (distance between the two hind limbs) was narrower in the MCAO 
group than the Control rats at 1 mo only (Hind base width, Fig 4D: U = 14, p < 0.05). 
Overlap of hind and forepaws during the walking cycle appeared to be reduced in the MCAO 
animals in comparison to the Control rats, however, this only achieved significance on the 
ipsilateral side at 1 mo (U = 18, p < 0.05). Additionally, stride length was only significantly 
increased in the MCAO group in comparison to the Control group at the 1 mo time point 
(Fig. 4D; U = 13.5, p < 0.05).  
 
Grip strength. The MCAO group required significantly more force than control animals to 
release the bars at both 1 and 2 mo (Fig. 4E; Groups; F1,22 = 4.36, p<0.05). Moreover, they 
exhibited no significant asymmetry between the two grip strength bars (Bias: n.s.) indicating 
no difference in grip strength between sides.  
 
Tests in which the MCAO animals did not exhibit significant deficits. 
 
 
Amphetamine induced rotations. Neither group exhibited any rotational asymmetries in 
response to amphetamine (net rotations: Control: 7.10 ± 46.75 vs MCAO: -8.22 ± 121.2, 
(Mean±SD); n.s.).  
 
Adhesive removal. The adhesive removal (‘sticky label’) test of somatosensory neglect 
showed no differences between groups at either time point (1 or 2 mo) in either the latency 
to contact or remove the labels affixed to either of their forepaws (Fig. 4F). 
 
Cylinder task. Although there appeared to be a small contralateral deficit in paw placing on 
the surface of the cylinder among the MCAO animals at 1 d, this was not significant and no 
significant bias in forelimb exploratory use was observed at any of the other post surgical 
time points (Fig. 4B) 
[Insert figure 4 here] 
 
Correlations of behavioural data with histological / MRI measures. A multiple correlational 
analysis was undertaken between the most robust tests (staircase task and apomorphine 
rotations), those that would be of utility (rotarod and lateralized stepping), and the 5 
measures of neuropathology (MRI hyperintensity; hemispheric, total white matter and striatal 
white matter atrophy; and striatal neuronal number). Individual results are summarised in 
Supplementary Table S1. Apomorphine induced rotations, rotarod and forehand lateralised 
stepping did not correlate with histological measures. In the staircase reaching test,  the 
number of pellets retrieved on the contralateral side over the last 5 days of training 
correlated positively with the number of surviving striatal neurons (ρ = 0.8, p < 0.01), and the 
hyperintense region on the MRI (ρ = -0.63, p < 0.05).  Additionally, the hyperintense region of 
the MRI significantly correlated will all neuropathological measures apart from the number of 
ipsilateral striatal neurons (ρ = 0.58 - .72, p all < 0.01).  
 
Discussion  
This extensive comparison of the most common tests for assessing motor and sensori-motor 
function following MCAO in rats has provided some interesting results. We consider that the 
most useful way of summarizing the tests is to rank them in terms of utility according to the 
underlying aim, which was to identify tests that are suitable at long-term time points in order 
to monitor stable deficits and the effects of potential therapeutics. Therefore, the tests were 
split into four categories: those which uncovered robust long-term deficits for up to 2 mo in 
MCAO animals, those in which MCAO animals exhibited subtle impairments but were not 
stable across time, those which failed to detect deficits in MCAO animals, and those in 
which the results appeared to be counter-intuitive, but still of potential utility. For a summary 
of this see Table 1. In order to further inform on the usefulness of these tests and assist in 
the design of future experiments, we performed sample size calculations on our data to 
compute group sizes required in order to observe a deficit in MCAO animals when 
compared to Controls at 2 mo for several of the tests (Table 2). This was taken a step 
further, and sample size calculations were performed on the MCAO data compared to a 
hypothetical MCAO group in which a 50% treatment effect would be required (Table 3).  
[Insert table 1 here] 
Robust tests  
Apomorphine-induced rotations robustly detected rotational bias in the MCAO animals at 2 
mo, which is consistent with other reports 6. The variability of this test was low, and as such 
achievable group sizes (50, Table 3) would be required in order to test a therapeutic 
intervention. However, the interaction between apomorphine with any therapy should be 
carefully considered. The other test that proved to be useful at long-term time points was 
skilled reaching using the staircase chambers. This is not entirely surprising as skilled 
reaching requires a high degree of motor coordination and tests like this have been 
consistently used by several groups to reveal subtle impairments and compensatory 
behaviours in many different animal models of neurological disease and degeneration 7. 
Unfortunately, tests such as these are not routinely used in pre-clinical stroke research. This 
might be due to the fact that pre-training the animals to perform in the test apparatus can be 
quite labour intensive and may extend over several weeks in order to first achieve stable 
baseline performance. Furthermore, there is the additional requirement of food restriction in 
order to motivate the animals to perform. This may conflict with the ability of this test to be 
employed in the acute MCAO post-operative period and may render the tests undesirable 
for many groups. Particularly as food restriction has been shown to induce long-term 
alterations in rodents, which may be beneficial, such as improving behavioural performance, 
enhancing neuroprotection and increasing longevity 8,9.  Furthermore, as is the case with the 
majority of behavioural assessments, there is variability between animals, so large group 
sizes are often required and this can be even more discouraging with tests that require large 
investment such as skilled reaching. Within our study, the staircase deficit was stable across 
block 2 - 4 of training, and approached significance on block 5. Therefore, it would be 
recommended to increase the sample size for this test, indeed large group sizes would be 
required for testing treatments (Table 3). A second type of skilled reaching, caged skilled 
reaching, did not reveal stable deficits. This may have been due to the variability of the data 
and the propensity of the rodents to compensate by using the non-affected paw (a factor 
that is not contributing in the staircase task where pellets on each side of the body can only 
be retrieved with the corresponding paw). As well as increasing the group size to account for 
this variability (n=37, Table 2), some groups lesion the side of the brain that corresponds to 
the preferred paw of each individual rodent. 
  
Tests in which MCAO animals exhibited subtle or transient impairments 
A number of tests showed impairments at some time points, and therefore could potentially 
be of utility with increased groups sizes or additional training. The rotarod has been used for 
detecting deficits in the MCAO animals by many groups 10,11, and the data presented here 
supports this. At 1 mo, the MCAO group was just shy of being significantly different from the 
Controls, though a significant difference was evident at 2 mo. Care in interpretation of these 
data is crucial: performance was stable in the MCAO group at both time points, whereas 
performance improved in the Control animals, indicating a significant degree of motor 
learning in the latter group 12. Therefore, it may be advantageous to expose the animals to 
extra training until stable/asymptotic performance is achieved both prior to and following 
surgery. Based on the 2 mo data, a sample size of only 27 (Table 3) would be required to 
detect a treatment effect. The corridor task, which is highly sensitive in rodent models of 
Parkinson’s disease 13, appeared to be somewhat useful for assessing deficits in the MCAO 
group as there was a slight bias that only just failed to achieve significance. Indeed, we have 
repeated this test in other groups of MCAO rats with 60 min occlusion and found that it is 
discriminatory between MCAO and Control rats. Based on the current data, sample size 
calculations indicate that group sizes of 38 animals would be required to observe deficits 
between Control and MCAO rats.  
 
Lateralized stepping was not consistent across all time points. Making adjusting steps in the 
forehand direction proved to be most difficult for MCAO rats at 1 d and 2 months: the same 
has been shown for the forelimb direction after distal MCAO (that affects only the cortex) out 
to 8 weeks 14. Backhand adjustment steps were most difficult at 7 d and 1 mo. Different 
measures from this task did reveal deficits across all time points, and as such, it should not 
be ruled out, particularly since this test is simple to administer 15,. The disengage task has 
been shown to reveal robust deficits in other animal models of striatal or nigro-striatal injury 
16. The ability to ‘disengage’ from feeding when exposed to a sensory stimulus (cotton bud 
stimulating the perioral region) on either side (impaired or intact) was examined and, an 
unexpected ispilateral deficit was evident with the chocolate distractor, unlike studies which 
have utilised this test in models of Parkinson’s disease 17. However, a difference was also 
evident on the contralateral side at 1 mo, which just failed to achieve significance, and it is 
possible that an increase in sample size may resolve this (31,Table 2).  
 In the modified neuroscore, an increased score was seen in the MCAO group at 1 and 7 d, 
however, this resolved by 1 mo post-MCAO. This is in line with other studies that show a 
high degree of recovery in neurological scores with time 18,19. While this test may detect 
deficits under certain conditions, for example in the short term after stroke, one major 
concern with employing tests in which there is spontaneous recovery is that, if a benefit from 
a therapeutic intervention is seen acutely post-MCAO, the experimenter will not know 
whether the treatment has truly improved functional capacity or has simply accelerated the 
spontaneous recovery which will naturally occur over the coming weeks. The ladder test was 
assessed at 1 and 2 mo and did not consistently show strong deficits. While the MCAO rats 
made more hindpaw slips and less forepaw slips on the regular spaced rungs at 1 mo, the 
overall number of foot slips was very low, indicating the rats did not struggle to cross. While 
a slight but non-significant increase in latency to cross the ladder was observed in both 
groups when the task was made increasingly difficult by spacing the rungs irregularly, the 
number of overall foot slips under this condition remained low.  
 
Counterintuitive tests  
A few tests provided results that may be considered unexpected or contrary to the initial 
hypothesis. On both the tapered balance beam and gait analysis, performance of the MCAO 
animals was significantly better at some time points compared to the Control group. For 
example, while the time to cross the tapered balance beam did not differ between the 
groups, the MCAO rats produced significantly less hindpaw slips at 1 mo. This was 
surprising, as the presence of the supporting ledge is thought to alleviate the fear associated 
with foot slips – which might otherwise lead to a fall – and thus deficits may be exaggerated. 
However, this may be explained by taking into account the results of the gait analysis, which 
showed the MCAO rats had a reduced hindpaw base width at 1 month, with a trend towards 
the same decrease at 2 months. While this is also unexpected (an increased base width has 
been associated with MCAO at longer time points 20), the reduced base width might mean 
the rats are less likely to slip as the hindlimbs are further away from the edge of the beam. It 
is possible this decrease in base width is a compensatory mechanism together with the 
increase in stride length. Indeed, in addition to a reported increase in base width, other 
groups have reported a mild decrease in stride length using a catwalk system in rats with 
occlusion durations of 60 min or more 18,20.  Thus, the duration of occlusion used in the 
present study may not have been sufficient to induce the magnitude of damage required to 
produce the same changes in parameters of gait. We also did not examine body weight as a 
potential confound, as was the case in the previous experiments.  
Swimming behaviour also provided interesting results. The MCAO rats made slightly more 
corrective fore paw strokes with the impaired forelimb at 1 mo. Though this did not achieve 
significance, it has been reported previously, and is often attributed to disinhibition of the 
forepaws which are not normally used for swimming in rats 21. However, MCAO rats did 
exhibit an increase in swim speed, which on the surface might imply they are swimming 
better than has previously been reported in this model 22. The increased swim speed may be 
due to the recruitment of forelimbs, or increased anxiety, which has also been reported 
before in this model 23, unfortunately anxiety was not measured in these animals.  
The MCAO rats also exhibited increased grip strength, although this seems unexpected, it 
has been reported before particularly in models of Parkinson’s disease 24. It is postulated 
that this is due to a reduction in the ability to initiate the movement to open the fore paw and 
release the bar, akin to dystonia.  
Although, appearing counterintuitive these tests still provide measures of dysfunction in 
these MCAO rats, and therefore may be of potential use if replicated in independent 
experiments. However, it is equally necessary to identify the underlying causes of these 
changes if the tests are to contribute to our understanding of the disease and potential 
treatments rather than simply provide further empirical measures of deficit and recovery.  
 
Tests in which MCAO animals did not exhibit deficits 
There were a number of tests that were not sensitive to deficits and even with increased 
sample sizes would be unlikely to demonstrate differences between MCAO and Control 
groups (Table 2).  One such test was amphetamine induced rotations. Rotational bias to 
amphetamine has been reported in the rat MCAO model previously 6,25, however these 
studies used longer occlusions times (60-120min) resulting in greater damage of the dorsal 
and medial striatum. Amphetamine rotation has classically been associated with dopamine 
denervation and re-innervation of the dorsal striatum 26, whereas, lateral lesions (the striatal 
area predominantly affected by MCAO) do not produce significant rotational asymmetry 27.  
Of particular interest is the fact that both the adhesive removal and cylinder tasks, which 
have been employed extensively in experimental stroke research, failed to reveal robust 
impairments at any of the tested time points. With the adhesive removal task, testing was 
only performed at 1 and 2 post-operative mo, therefore, there is the potential that deficits 
may have been seen at earlier time points. Indeed, the magnitude of the somatosensory 
asymmetry has been shown to be larger at acute time points (1-14 d) but decreases in the 
chronic phase (21-30 d) using a more severe permanent proximal occlusion of the MCAO 28. 
The fact we observed a very small (but non significant) bias in time to contact at 1 mo, would 
support the notion that spontaneous recovery on this test may occur. Interestingly, the most 
common caveat we experienced with this test was that the rats (both Control and MCAO) 
ignored the stimuli and took quite a long time to contact them. This could potentially be due 
to the fact that the rats in this study were very well handled and did not find the 
administration of the sticky tape aversive. A similar effect for the cylinder task, in that at 
chronic time points limb use deficits were not as pronounced, has also been reported  28. 
Although,  with the proximal permeant MCAO model deficits up to 28 days have been seen 
in this task29. With tests such as the cylinder that rely on natural exploratory behaviour, there 
is the potential confound that rodents lose interest with time, particularly when well 
habituated to the environment, and this may also have been a contributing factor. 
Limitations  
Some limitations of our experiments include the choice of rat strain and the high incidence of 
sub-arachnoid hemorrhage. The present study used Wistar rats and these results may not 
transfer directly to other strains, as there are significant differences in the way different 
strains respond on behavioural tasks 11. Approximately 20% of animals were excluded due 
to the lack of restoration of cerebral blood flow following removal of the filament. In all cases, 
animals were euthanized during surgery and a sub-arachnoid haemorrhage was found on 
post-mortem examination. High haemorrhage rates are unfortunately not uncommon with 
this model. However, we would like to point out that, within our laboratory, we now use 
Doccol filaments (Doccol corporation, USA), which has significantly reduced this adverse 
event. It should also be noted that behavioural testing was carried out during the light cycle. 
Time of testing has been shown to have an effect on rodent performance, particularly on 
cognitive tasks 30. 
 
Despite the fact that we aimed to produce small lesions, the short occlusion time (30 min) is 
associated with a few limitations. For example, there was a high rate of failure of the model 
(15% of animals were excluded due to incomplete MCAO). While it is possible to increase 
the occlusion time to obtain larger infarcts, it is widely acknowledged that incomplete MCAO 
is a common limitation of this model and not completely dependent on occlusion duration. 
The smaller lesions may also explain the lack of deficits in some tests and it is possible 
these tests are more suitable for rodents with large, extensive infarcts 6,25. However, it is 
important to point out that the filament model has the potential to produce large lesions that 
could be considered to resemble malignant infarctions in humans. In this situation, rodents 
often receive the poorest outcome scores due to reluctance or the inability to participate in 
the test. It has been argued that tests that only detect deficits at acute time points, or in 
animals with extensive infarcts (such as  neurological score) may simply be more sensitive 
to morbidity outcomes and not necessarily due to sensori-motor impairments. We therefore 
feel that obtaining smaller lesions, in which the overall impact on health was not as great a 
contributing factor, was an advantage to our study. Furthermore, tests that are robust 
enough to detect deficits in this smaller lesion model should be applicable in the inverse 
situation, provided the health of the animals has recovered sufficiently to participate. Finally, 
a large number of behavioural tests were used in this study, something that would not be 
recommended for routine use or in a therapeutic study. In itself, this may have acted as an 
intervention, enriching the rat’s environment and/or providing some degree of physical 
therapy, and thereby reducing the magnitude of deficits on individual tasks that would have 
been seen if they had been conducted alone. However, even if this was the case, and the 
extensive testing provided some degree of practice, compensation, neuroprotection or 
enhanced endogenous plasticity, the aims were still met as only tasks that are stable and 
robust would have been significant. Furthermore, in the clinical context, it is best practice to 
provide stroke patients with physical therapy, so the extensive training provided in the 
present experiment will further help to avoid false positives. On average, rats were given 8 – 
15 minutes of testing each day, for 20-25 days in total, which is more enrichment than 
received in a standard laboratory environment, but it is also not considered excessive.  
 
In conclusion, sensitive and robust tests that do not show spontaneous recovery and are 
performed within extended time windows are required if novel therapeutic strategies are to 
be successful. Here we demonstrate a number of tests, including lateralized stepping, 
rotarod, apomorphine induced rotations and the staircase task that were all able to detect 
long-term deficits in the relatively mild rat 30 min filament MCAO model. It is important to 
highlight that, even with these tests, both the variability of the model and the inherent 
variability seen between animals when assessing behaviour, necessitates large group sizes. 
To assist with this we provide sample size calculations from the data in the present study to 
assist with future experimental design, including testing of therapies with an effect size of 
50%. 
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Figures 
 
Figure 1, Outline of the experimental design and tasks performed by Cohort 1 and 2.  
 
 
 
 
 
 
 
 
 
 Figure 2, Assessment of MCAO neuropathology in Cohorts 1 and 2. A) Hyperintense 
volume on MRI at 24 h post MCAO surgery. B) Percentage of hemispheric atrophy from 
histology at 2 mo. C) Percentage of striatal white matter atrophy, and D) Percentage of total 
hemisphere white matter atrophy calculated from solochrome cyanine stained sections at 2 
mo. E) Striatal NeuN cell loss as a percentage of the total number of cells in the Control 
group. F and G) Representative T2 maps from animals in Cohort 1 and 2, respectively. All 
graphs show mean ± standard deviation (SD), n = 11 and 9 for MRI and 10 and 9 for all 
other measures. No signifcant differences were found between the two Cohorts.  
 Figure 3, Summary of tests in which MCAO animals exhibited deficits. A) Pellets retrieved 
with each forelimb in the staircase task at 2 mo (Cohort 1: n = 14 Control, n = 11 MCAO). B) 
Latency to fall from the Rotarod at 1 and 2 mo (Cohort 1: n = 14 Control, n = 11 MCAO). C) 
Forehand and backhand steps during lateralized stepping (both cohorts at 1 d: n= 19 
Control, n = 20 MCAO, at 7 d: n = 19 Control, n = 19 MCAO, at 1 mo: n = 23 Control, n = 18 
MCAO, and at 2 mo: n = 24 Control, n = 20 MCAO). D) Modified neuroscore (both cohorts: n 
= 24 Control, n = 20 MCAO). E) Time to criterion and number of failed reaches in the cage 
reaching task at 1 and 2 mo (Cohort 1: at 1 mo: n = 13  Control, n = 11 MCAO, at 2 mo: n = 
13 Control, n =11 MCAO). F) Bias in the corridor task at 1 and 2 mo (Cohort 1: n = 14 
Control, n = 11 MCAO). G) Latency to respond with and without the chocolate distractor in 
the disengage task (Cohort 2: n= 10 Control, n = 9 MCAO, except at 1 mo. with chocolate 
distractor for the contralateral paw: n = 10 Control, n = 8 MCAO). H) Latency to cross for 
regular and irregular rungs in the ladder test at 1 and 2 mo (Cohort 2: n = 10 Control, n = 9 
MCAO). Data is expressed as median, minimum and maximum values in the box and 
whisker plots and as means ± standard deviation (SD) with individual values in the scatter 
plots. Note: the dotted line represents 50% bias (no preference for either side or paw). * = p 
<0.05, ** = p < 0.01, *** p < 0.001.  
 
 
 Figure 4, Summary of tests in which the MCAO animals exhibited no deficits (B and F) or 
tests that were counterintuitive (A, C, D, and E). A) Number of fore and hindpaw strokes 
during swimming analysis at 1 and 2 mo (Cohort 2: n = 10 Control, n = 9 MCAO). B) 
Forelimb exploring bias in the cylinder task (Cohort 1: at 1 d: n = 14 Control, n = 11 MCAO, 
at 7 d: n = 12 Control, n = 11 MCAO, at 1 mo: n = 14 Control, n = 11 MCAO, and at 2 mo n 
= 10 Control, n = 8 MCAO). C) Hind and forepaw slips and time to cross the tapered 
balance beam at 1 and 2 mo (Cohort 2: n = 10 Control, n = 9 MCAO). D) Paw base width, 
paw placement overlap, and stride length during gait analysis at 1 and 2 mo (Cohort 2: at 1 
mo: n = 9 control, n = 9 MCAO, and at 2 mo: n = 10 Control, n = 9 MCAO). E) Force 
required to release and side bias during grip strength at 1 and 2 mo (Cohort 1: n = 14 
Control, n = 11 MCAO). F) Contact and removal bias during adhesive removal at 1 and 2 mo 
(Cohort 2: n = 10 Control, n = 9 MCAO, except at 1 mo for remove: n = 9 Control, n = 9 
MCAO). Data is expressed as means ± SD with individual values in the scatter plots. Note: 
The dotted line represents 50% bias (no preference for either side or paw). * = p <0.05, ** = 
p < 0.01, *** p < 0.001.  
 
Tables 
 1 d 7 days 1 month  2 months  
Both 
cohorts 
modified 
neurological 
score 
lateralized 
stepping 
modified 
neurological 
score 
lateralized 
stepping 
modified neurological 
score 
lateralized stepping 
 
modified neurological 
score 
lateralized stepping 
 
Cohort 1 
 
cylinder task cylinder task cylinder task 
cage-reaching 
grip strength 
rotarod   
corridor task 
 
 
cylinder task 
cage-reaching 
grip strength 
rotarod   
corridor task 
staircase task* 
(*on days 38 to 63) 
Cohort 2 
 
  tapered balance beam   
disengage task 
gait analysis 
ladder test 
adhesive removal  
swimming analysis 
 
 
tapered balance beam   
disengage task 
gait analysis 
ladder test 
adhesive removal  
swimming analysis 
Drug induced rotations: 
Apomorphine, 
Amphetamine 
Table 1  
Table 1: Summary of results. The tests underlined and in bold detected significant 
differences between the control and MCAO groups.  
 
 
 
 
 
 
Test           Measure  Sample Size (per group) 
Gait analysis  Hind paw base width 24 
Disengage with distractor Latency (contralateral) 31 
Tapered balance beam Latency 33 
Modified Neuroscore 
 
36 
Cage reaching  Latency to criterion 37 
Corridor Bias 38 
Irregular ladder Latency 44 
Cage reaching  Failed reaches (contralateral) 59 
Adhesive removal  Bias (remove) 208 
Drug induced rotations Amphetamine 473 
Disengage without distractor  Latency (contralateral) 552 
Cylinder  Bias 818 
Adhesive removal Bias (contact) 1137 
Regular ladder  Hind foot slips 10748 
Table 2 
Table 2: Sample size calculations for MCAO vs Control, based on the variance and 
difference between groups at the 2 month time point. Power = 0.8, α = 0.05.  
 
 
 
Test Measure  Sample Size (per group) 
Swimming analysis Latency 20 
Rotarod Latency 27 
Drug induced rotations Apomorphine 50 
Lateralised Stepping Bias (forehand) 66 
Staircase reaching Pellets retrieved  (contralateral) 84 
Gait analysis  Hindpaw base width 87 
Irregular ladder Latency 107 
Tapered balance beam Latency 124 
Corridor Bias 145 
Disengage with distractor Latency (contralateral) 168 
Modified Neuroscore 
 
168 
Cage reaching  Latency to criteron 277 
Gripstrength (AU) 279 
Cage reaching  Failed reaches (contralateral) 394 
Table 3 
Table 3: Sample size calculations for MCAO Vs treated MCAO (with anticipated 50% in 
improvement) based on the variance and difference between groups at the 2 month time 
point. Power = 0.8, α = 0.05. 
